[1] Sung H, Ferlay J, Siegel RL, et al.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. [2] Ferlay J, Colombet M, Soerjomataram I, et al.Cancer statistics for the year 2020: An overview[J]. Int J Cancer 2021, 149(4): 778-789. [3] Xie Y, Shi L, He X, et al.Gastrointestinal cancers in China, the USA, and Europe[J]. Gastroenterol Rep (Oxf), 2021, 9(2): 91-104. [4] Marquardt JU, Andersen JB, Thorgeirsson SS.Functional and genetic deconstruction of the cellular origin in liver cancer[J]. Nat Rev Cancer, 2015, 15(11): 653-667. [5] Wang H, Tang F, Bian E, et al.IFITM3/STAT3 axis promotes glioma cells invasion and is modulated by TGF-beta[J]. Mol Biol Rep, 2020, 47(1): 433-441. [6] Li H, Yang LL, Wu CC, et al.Expression and Prognostic Value of IFIT1 and IFITM3 in Head and Neck Squamous Cell Carcinoma[J]. Am J Clin Pathol, 2020, 153(5): 618-629. [7] Xu L, Chen J, Jia L, et al.SLC1A3 promotes gastric cancer progression via the PI3K/AKT signalling pathway[J]. J Cell Mol Med, 2020, 24(24): 14392-14404. [8] Fattahi S, Amjadi-Moheb F, Tabaripour R, et al.PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond[J]. Life Sci, 2020, 262: 118513. [9] Chen S, Wei Y, Liu H, et al.Analysis of Collagen type X alpha 1 (COL10A1) expression and prognostic significance in gastric cancer based on bioinformatics[J]. Bioengineered, 2021, 12(1): 127-137. [10] Yu H, Zhao K, Zeng H, et al.N(6)-methyladenosine (m(6)A) methyltransferase WTAP accelerates the Warburg effect of gastric cancer through regulating HK2 stability[J]. Biomed Pharmacother, 2021, 133: 111075. [11] Alghamdi J, Alaamery M, Barhoumi T, et al.Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortality[J]. Genomics, 2021, 113(4): 1733-1741. [12] Schonfelder K, Breuckmann K, Elsner C, et al.The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19[J]. Cytokine, 2021, 142: 155492. [13] Shi G, Kenney AD, Kudryashova E, et al.Opposing activities of IFITM proteins in SARS-CoV-2 infection[J]. EMBO J, 2021, 40(3): e106501. [14] Zhu X, Shen Z, Man D, et al.miR-152-3p Affects the Progression of Colon Cancer via the KLF4/IFITM3 Axis[J]. Comput Math Methods Med, 2020, 2020: 8209504. [15] Hu J, Wang S, Zhao Y, et al.Mechanism and biological significance of the overexpression of IFITM3 in gastric cancer[J]. Oncol Rep, 2014, 32(6): 2648-2656. [16] Gan CP, Sam KK, Yee PS, et al.IFITM3 knockdown reduces the expression of CCND1 and CDK4 and suppresses the growth of oral squamous cell carcinoma cells[J]. Cell Oncol (Dordr), 2019, 42(4): 477-490. [17] Min J, Feng Q, Liao W, et al.IFITM3 promotes hepatocellular carcinoma invasion and metastasis by regulating MMP9 through p38/MAPK signaling[J]. FEBS Open Bio, 2018, 8(8): 1299-1311. [18] Liu X, Chen L, Fan Y, et al.IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-beta signaling pathway[J]. Cell Death Dis, 2019, 10(7): 517. [19] Min J, Hu J, Luo C, et al.IFITM3 upregulates c-myc expression to promote hepatocellular carcinoma proliferation via the ERK1/2 signalling pathway[J]. Biosci Trends, 2020, 13(6): 523-529. [20] Liu W, Feng Q, Liao W, et al.TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a[J]. J Cancer, 2021, 12(22): 6905-6920. [21] Ye Y, Ye F, Li X, et al.3,3'-diindolylmethane exerts antiproliferation and apoptosis induction by TRAF2-p38 axis in gastric cancer[J]. Anticancer Drugs, 2021, 32(2): 189-202. [22] Huang N, Cui X, Li W, et al.IL33/ST2 promotes the malignant progression of gastric cancer via the MAPK pathway[J]. Mol Med Rep, 2021, 23(5): 361. [23] Yang H, Liu G, Zhao H, et al.Inhibiting the JNK/ERK signaling pathway with geraniol for attenuating the proliferation of human gastric adenocarcinoma AGS cells[J]. J Biochem Mol Toxicol, 2021, 35(8): e22818. |